Equities

Dedicare AB (publ)

Dedicare AB (publ)

Actions
Health CareHealth Care Providers
  • Price (SEK)70.70
  • Today's Change0.00 / 0.00%
  • Shares traded9.15k
  • 1 Year change-18.83%
  • Beta0.8162
Data delayed at least 15 minutes, as of Sep 20 2024 11:22 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in SEKIncome statement in SEKView more

Year on year Dedicare AB (publ) grew revenues 11.46% from 1.77bn to 1.97bn while net income improved 8.99% from 101.30m to 110.40m.
Gross margin--
Net profit margin4.77%
Operating margin5.92%
Return on assets12.97%
Return on equity32.97%
Return on investment26.31%
More ▼

Cash flow in SEKView more

In 2023, Dedicare AB (publ) increased its cash reserves by 31.06%, or 44.35m. The company earned 145.40m from its operations for a Cash Flow Margin of 7.38%. In addition the company used 9.67m on investing activities and also paid 81.83m in financing cash flows.
Cash flow per share11.53
Price/Cash flow per share4.80
Book value per share29.13
Tangible book value per share11.83
More ▼

Balance sheet in SEKView more

Dedicare AB (publ) has a Debt to Total Capital ratio of 22.48%, a lower figure than the previous year's 33.33%.
Current ratio1.32
Quick ratio--
Total debt/total equity0.29
Total debt/total capital0.2248
More ▼

Growth rates in SEK

Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 8.33% and 8.03%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Business Services industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth is in-line with the industry average relative to its peers, while earnings per share growth is above the industry average.
Div yield(5 year avg)4.60%
Div growth rate (5 year)10.20%
Payout ratio (TTM)70.07%
EPS growth(5 years)22.06
EPS (TTM) vs
TTM 1 year ago
-13.14
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.